Technology

electronic-circuit-board-closeup

For firms that aim to capitalise on the revamp of over-the-counter derivatives markets, now is no time to arrange a parade. It will probably get rained on.

One by one, each of the obvious beneficiaries of the OTC market structure revolution has had its hoped-for advantage eroded, called into question or wiped out at a stroke. Clearing houses will play a pivotal role in the new market – there is no question of that – but the incumbent clearers that were in the strongest position to benefit from

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: